Home › Funds › Aldebaran Capital, LLC › ANTX
Aldebaran Capital, LLC position in ANTX
AN2 THERAPEUTICS INC · Health Care
Aldebaran Capital, LLC reported holding 367,706 shares of ANTX (AN2 THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$2.0M, representing 1.41% of its reported portfolio and ranking #22 among its reported holdings. Aldebaran Capital, LLC has disclosed ANTX holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Aldebaran Capital, LLC's ANTX position evolved
Aldebaran Capital, LLC first disclosed a stake in ANTX in Q3 2024 at 100,500 shares (US$108K). The position peaked in Q3 2026 at 367,706 shares, worth US$2.0M. Across 9 filings, Aldebaran Capital, LLC increased the stake 2 time(s), trimmed it 5 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 367,706 shares valued at US$2.0M. Notable position changes include a 242% increase in Q4 2024 (shares fell 1% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 100.50K | $107.53K | New |
| Q4 2024 | 343.68K | $474.28K | Add |
| Q1 2025 | 406.62K | $553.01K | Add |
| Q2 2025 | 402.75K | $426.92K | Reduce |
| Q3 2025 | 392.75K | $498.80K | Reduce |
| Q4 2025 | 376.77K | $429.52K | Reduce |
| Q1 2026 | 371.77K | $1.27M | Reduce |
| Q2 2026 | 367.44K | $1.78M | Reduce |
| Q3 2026 | 367.71K | $1.96M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ANTX and 13F data
ANTX (AN2 THERAPEUTICS INC) is a Health Care company. 44 other funds we track also report a position in ANTX — the largest reported positions include Vivo Capital, LLC (US$16.8M), Commodore Capital LP (US$14.2M), Spruce Street Capital LP (US$8.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ANTX
- Vivo Capital, LLC 3.15M sh · $16.78M · Q3 2026
- Commodore Capital LP 2.93M sh · $14.20M · Q2 2026
- Spruce Street Capital LP 1.66M sh · $8.04M · Q2 2026
- Almitas Capital LLC 1.47M sh · $7.11M · Q2 2026
- Boxer Capital Management, LLC 749.03K sh · $3.63M · Q2 2026
- Stonepine Capital Management, LLC 551.69K sh · $2.67M · Q2 2026
- Sio Capital Management, LLC 529.93K sh · $2.56M · Q2 2026
- Ally Bridge Group (NY) LLC 526.32K sh · $2.55M · Q2 2026
- Prosight Management, LP 474.64K sh · $2.30M · Q2 2026
- Velan Capital Investment Management LP 40.00K sh · $193.60K · Q2 2026
More on Aldebaran Capital, LLC
FAQ
How long has Aldebaran Capital, LLC held ANTX?
Aldebaran Capital, LLC has disclosed ANTX holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
What is Aldebaran Capital, LLC's current position in ANTX?
As of Q3 2026, Aldebaran Capital, LLC holds 367.71K shares of ANTX (AN2 THERAPEUTICS INC), valued at $1.96M, representing 1.41% of its reported portfolio and ranking #22.
Has Aldebaran Capital, LLC been buying or selling ANTX?
In the latest 13F filing (Q3 2026), Aldebaran Capital, LLC held unchanged its position in ANTX. The position peaked in Q3 2026 at 367.71K shares.
Which other funds hold ANTX?
Other major institutional holders of ANTX include Vivo Capital, LLC, Commodore Capital LP, Spruce Street Capital LP, among 44 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.